Atlas Trials

Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.

Clinical trial NCT06449027 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06449027
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer Subjects
Start date
2024-08-21
Primary completion
2025-11-01
Enrollment
211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.